Using Whole Body MRI to Improve Cancer Detection
Official title: Whole Body MRI in Oncology
Run by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · NCT06895291 · Data updated 2026-11-12
This study is testing if Whole Body MRI can help find bone and soft tissue problems in people with different types of cancer, like lymphoma and advanced prostate and breast cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS Academic / other |
| Drugs / interventions | radiation |
| Locations | 3 sites (Bologna, BO and 2 other locations) |
| Status | Recruiting |
| Started | October 26, 2023 |
| Main results expected | October 2028 |
| Study ends | October 2031 |
| Registry record updated | March 30, 2025 |
| Trial ID | NCT06895291 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with specific cancers who are eligible for WB-MRI according to clinical practice.
✕Probably not a fit
Patients with MRI-unsafe prostheses or devices, or those unable to complete the MRI, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the effectiveness of Whole Body Magnetic Resonance Imaging (WB-MRI) in detecting bone and soft tissue pathology in patients with various cancers, including lymphoma and advanced prostate and breast cancer. Patients will undergo WB-MRI as part of their routine clinical care without any additional procedures. The study aims to assess the imaging technique's ability to provide high-quality morphological images and functional information about tissue cellularity. The findings could help establish WB-MRI as a standard imaging method in oncology.
Why it matters
Potential benefit: If successful, this study could enhance cancer detection and monitoring, leading to better patient outcomes.
How similar studies have gone: Previous studies have shown promising results with WB-MRI in oncology, indicating its potential as a valuable imaging technique.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients candidate to WB-MRI according to clinical practice belonging to the study groups listed above. * Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged ≥ 18 years. * Life expectancy greater than 3 months. Exclusion Criteria: * Patients with MRI-unsafe prostheses and devices. * Patients whose tests are of suboptimal quality, or whose test has been suspended, or is incomplete.
Where it's running
-
IRCCS - Azienda Ospedaliero-Universitaria di Bologna - Policlinico di S. Orsola
Bologna, Bo, Italy Recruiting -
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l.
Meldola, Fc, Italy Recruiting -
IRCCS Istituto Europeo di Oncologia S.r.l.
Milan, Mi, Italy Not yet recruiting
Study contacts
- Principal investigator: Alice Rossi — IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l.
- Study coordinator: Oriana Nanni
- Email: cc.ubsc@irst.emr.it
- Phone: +390543739266
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prolonged overnight fasting combined with a Mediterranean-style diet for people with multiple myeloma or precursor conditions
This program will test whether longer overnight fasting paired with a Mediterranean-style eating plan is doable for adults with MGUS, smoldering myeloma, or newly diagnosed multiple myeloma who are starting treatment.
-
Understanding different types of multiple myeloma precursor conditions
This study is trying to tell the difference between two early stages of multiple myeloma, smoldering multiple myeloma and monoclonal gammopathy of undetermined significance, to better understand how they progress or stay stable.
-
Tailored exercise program to improve quality of life for adults with hematologic cancers
This pilot trial tests a personalized 16-week exercise program to see if it’s feasible and helpful for adults with acute myeloid leukemia, lymphoma, or multiple myeloma after first-line treatment.
-
Low-dose Liposomal Amphotericin B for preventing fungal infections in adults with blood cancers and prolonged neutropenia
This study tests whether giving a daily 50 mg dose of liposomal amphotericin B can help prevent invasive fungal infections in adults with blood cancers who have prolonged low white blood cell counts.
-
AI-generated personalized question lists to help people with lymphoma or multiple myeloma prepare for clinic visits.
This study will test whether AI-generated personalized question lists help people with lymphoma or multiple myeloma ask better questions and get more useful information during outpatient appointments.
-
High-altitude stem cell and bone marrow transplant registry on the Qinghai-Tibet Plateau
This project will collect clinical data and blood/bone marrow samples from people having hematopoietic stem cell transplants on the Qinghai‑Tibet Plateau to see how high altitude affects transplant outcomes and recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.